Patients, Privacy, and PDMPs: Exploring the Impact of Prescription Drug Monitoring Programs

The Cato Institute
01:30:45 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (63)

0:00 Prescription Drug Monitoring Programs chapter 3
0:00 Prescription Drug Monitoring Programs
2:07 Opioid Misuse and Addiction Statistics
3:51 Rise in Opioid Overdose Deaths Since 1970s
5:42 Impact of Prescription Drug Monitoring Programs chapter 4
5:42 Pain Management Under Prescription Pressure
7:14 Effectiveness of PDMPs on Prescription and Overdose Rates
8:34 Epidemiology and Public Health Research Discussion
10:21 Opioid Crisis and Prescription Monitoring Programs
12:44 Effectiveness of PDMPs on Prescription Behavior chapter 3
12:44 Effectiveness of PDMPs on Prescription Behavior
14:45 Effectiveness of PDMPs and Pain Clinic Laws
16:24 Effectiveness of PDMPs in Reducing Opioid Poisonings
18:52 Insufficiency of PDMPs in Addressing Opioid Harms chapter 2
18:52 Opioid Program Effects on Patient Care
20:52 Impact of PDMPs on Patient Safety
23:17 Risks of Prescription Monitoring Programs chapter 3
23:17 Concerns about PDMPs and Patient Care
24:58 Risks of Abrupt Medication Discontinuation
26:42 Barriers to Care from Flagging Patients
28:42 Opioid Prescribing Restrictions and Patient Harm chapter 3
28:42 Rural Healthcare Barriers and Opioid Access
30:21 Opioid Prescribing Practices Under Scrutiny
31:52 Physician Prescribing Practices Under Surveillance
33:16 Medical Professionals Fear Liability and Judgment chapter 3
33:16 Medical Professionals Fear Liability and Judgment
34:51 Opioid Discontinuation and Patient Care Concerns
36:34 APRA's Narcs Care Score Raises Concerns
39:02 Opioid Treatment and PDMP Concerns chapter 3
39:02 Opioid Treatment and PDMP Concerns
41:32 Law Enforcement Access to Medical Records
43:04 Tampered Morphine in Utah Fire Department
45:08 Abuse of Power in Prescription Data Access chapter 2
45:08 Abuse of Power in Prescription Data Access
47:23 Law Enforcement Access to Prescription Data
49:23 Law Enforcement Access to Prescription Data chapter 3
49:23 Law Enforcement Access to Prescription Data
51:08 Law Enforcement Access to Prescription Data
53:19 State Laws Challenge Federal Subpoena Requirements
54:40 Fourth Amendment Protections for Medical Data chapter 3
54:40 Fourth Amendment and Digital Data Protection
56:33 Prescription Drug Monitoring Programs Effectiveness
58:25 Opioid Crisis and PDMP Approaches
1:00:24 PDMP Participation and Reporting Variations chapter 2
1:00:24 PDMP Reporting and Access Variations
1:03:22 PDMP Data Access for Law Enforcement
1:05:04 Evaluating Prescription Drug Monitoring Program Effectiveness chapter 2
1:05:04 Evaluating Prescription Drug Monitoring Programs Effectiveness
1:07:47 Improving Patient Safety with PDMP Data
1:10:24 PDMP Data Use and Misapplication Concerns chapter 3
1:10:24 Opioid Therapy and Data Dissemination Considerations
1:12:00 Enhancing PDMP Data Dissemination and Use
1:13:35 Balancing PDMPs with Patient Care Concerns
1:16:02 Opioid Crisis and PDMPs Limitations chapter 3
1:16:02 Opioid Crisis and PDMPs Utility
1:17:33 Chronic Pain Patients Overburdened by PDMPs
1:19:29 Public Health Tool Misused as Law Enforcement
1:21:51 Opioid Crisis and Recalibration Efforts chapter 2
1:21:51 Opioid Crisis and Overdose Prevention Strategies
1:24:09 Correcting Deficiencies in PDMP
1:26:33 Policymaker Understanding of Complex Medical Issues chapter 2
1:26:33 Policymaker Understanding of Complex Medical Issues
1:28:30 Pharmacy Regulation and Patient Data Protection

Transcript

Loading transcript...